High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism.
暂无分享,去创建一个
M. Rotondi | M. Serio | E. Ferrannini | A. Antonelli | S. Ferrari | P. Fallahi | P. Romagnani | A. Buonamano
[1] M. Salvadori,et al. High Pretransplant Serum Levels of CXCL10/IP‐10 Are Related to Increased Risk of Renal Allograft Failure , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] A. Weetman,et al. Detection and localization of chemokine gene expression in autoimmune thyroid disease , 2003, Clinical endocrinology.
[3] Sergio Romagnani,et al. An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4 , 2003, The Journal of experimental medicine.
[4] E. Ferrannini,et al. Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer. , 2003, Thyroid : official journal of the American Thyroid Association.
[5] M. Rotondi,et al. Role for interferon-γ inducible chemokines in endocrine autoimmunity: An expanding field , 2003 .
[6] Y. Tomer,et al. The genetics of the autoimmune thyroid diseases. , 2003, Annales d'endocrinologie.
[7] A. Weetman. Autoimmune thyroid disease: propagation and progression. , 2003, European journal of endocrinology.
[8] F. Nicoletti,et al. Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease , 2002, Diabetologia.
[9] Luca Chiovato,et al. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. , 2002, The American journal of pathology.
[10] G. Stassi,et al. Autoimmune thyroid disease: new models of cell death in autoimmunity , 2002, Nature Reviews Immunology.
[11] Su He Wang,et al. A Unique Combination of Inflammatory Cytokines Enhances Apoptosis of Thyroid Follicular Cells and Transforms Nondestructive to Destructive Thyroiditis in Experimental Autoimmune Thyroiditis1 , 2002, The Journal of Immunology.
[12] D. Adams,et al. Recruitment of lymphocytes to the human liver , 2002, Immunology and cell biology.
[13] M. Salvadori,et al. IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. , 2002, Journal of the American Society of Nephrology : JASN.
[14] Claudio Ronco,et al. Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique. , 2002, Journal of the American Society of Nephrology : JASN.
[15] P. Marchetti,et al. Anti‐CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease , 2001, Clinical and experimental immunology.
[16] F. Sánchez‐Madrid,et al. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. , 2001, The Journal of clinical endocrinology and metabolism.
[17] Y Oikawa,et al. Elevated serum IP-10 levels observed in type 1 diabetes. , 2001, Diabetes care.
[18] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[19] M. Serio,et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. , 2001, The Journal of clinical investigation.
[20] M. Springer,et al. The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. , 2000, Current opinion in chemical biology.
[21] Koichi Suzuki,et al. Hypothyroidism in transgenic mice expressing IFN-γ in the thyroid , 2000 .
[22] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[23] P. Vitti,et al. Grey scale thyroid ultrasonography in the evaluation of patients with Graves' disease. , 2000, European journal of endocrinology.
[24] A. Zlotnik,et al. The biology of chemokines and their receptors. , 2000, Annual review of immunology.
[25] A. Antonelli,et al. Thyroid cancer in patients with hepatitis C infection. , 1999, JAMA.
[26] T. Bakács,et al. Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma. , 1999, JAMA.
[27] W. Wiersinga,et al. Ultrasonographic versus scintigraphic measurement of thyroid volume in patients referred for 131I therapy. , 1998, Nuclear medicine communications.
[28] R. Strieter,et al. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. , 1999, Journal of leukocyte biology.
[29] A. Antonelli,et al. Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. , 1997, Thyroid : official journal of the American Thyroid Association.
[30] Elena S. Di Martino,et al. Thyroid blood flow evaluation by color-flow doppler sonography distinguishes Graves’ disease from Hashimoto’s thyroiditis , 1995, Journal of endocrinological investigation.
[31] M. Ferdeghini,et al. Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. , 1995, Thyroid : official journal of the American Thyroid Association.
[32] R. Goswami. High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy. , 1992, Acta endocrinologica.